Back to Search
MICHAEL TOMBLYN MD
MD
Radiation Oncology Physician
NPI: 1083758544IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
036140023(IL)62366(TN)
Therapeutic Radiology Physician
Radiology — Therapeutic Radiology
Code: 2085R0203X
ME104123(FL)
Education
RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Class of 2004
Research & Publications (16)
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
PMID 18806838·Bone Marrow Transplant·2009
8-other
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
PMID 19581540·J Clin Oncol·2009
4-observational
Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.
PMID 19539219·Biol Blood Marrow Transplant·2009
3-trial
Second hematopoietic stem cell transplantation in myeloid malignancies.
PMID 19468273·Curr Opin Hematol·2009
6-review
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
PMID 19167681·Biol Blood Marrow Transplant·2009
3-trial
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.
PMID 19151792·Bone Marrow Transplant·2009
3-trial
Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation.
PMID 18410896·Biol Blood Marrow Transplant·2008
4-observational
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
PMID 18275894·Biol Blood Marrow Transplant·2008
3-trial
Donor lymphocyte infusions: the long and winding road: how should it be traveled?
PMID 18711351·Bone Marrow Transplant·2008
6-review
Are there circumstances in which phase 2 study results should be practice-changing?
PMID 18024669·Hematology Am Soc Hematol Educ Program·2007
6-review
Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
PMID 17530003·Bone Marrow Transplant·2007
8-other
Helical tomotherapy targeting total bone marrow - first clinical experience at the University of Minnesota.
PMID 17453378·Acta Oncol·2007
8-other
Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF.
PMID 16062175·Bone Marrow Transplant·2005
8-other
Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
PMID 12820773·Expert Rev Anticancer Ther·2003
6-review
New developments in antibody therapy for acute myeloid leukemia.
PMID 12939719·Semin Oncol·2003
6-review
Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea.
PMID 12379891·Bone Marrow Transplant·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
4.3(553)
Via Mid South Internal Medicine · 2 locations total
- Address
- 6019 WALNUT GROVE RD
MEMPHIS, TN 38120 - Phone
- (901) 226-0340
- Website
- midsouthinternalmedicine.com
- HoursClosed
Monday: 8:00 AM – 4:30 PM
Tuesday: 8:00 AM – 4:30 PM
Wednesday: 8:00 AM – 4:30 PM
Thursday: 8:00 AM – 4:30 PM
Friday: 8:00 AM – 4:30 PM
Saturday: Closed
Sunday: Closed
4.3(553)
See full reviewsQuick Facts
- NPI
- 1083758544
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 22
- Publications
- 16
Are you this provider?
Claim Your Profile